Previous 10 |
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc. (Nasdaq: SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced that Elizabeth “Liz” Nguyen has been appointed as Vice Pres...
Gainers: Helbiz (NASDAQ:HLBZ) +128%. NanoViricides (NYSE:NNVC) +100%. ReWalk Robotics (NASDAQ:RWLK) +56%. Spire (NYSE:SPIR) +30%. Corvus (NASDAQ:CRVS) +29%. Inotiv (NASDAQ:NOTV) +26%. Candel (NASDAQ:CADL) +23%. Rockley (NYSE:RKLY) +19%. Protagonist (NASDAQ:PTGX) +18%. indie Semiconductor (NAS...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The major averages closed near sessions lows, with the S&P 500 (SP500), -0.8%, logging five straight losing days for the first time since...
Healthcare stocks in the S&P 500 underperformed the ~1.7% loss in the broader index to end ~2.7% lower over the holiday-shortened week to record their worst weekly performance since November. Among healthcare stocks with more than $300M market cap and over 100K average daily vol...
Are These Top Biotech Stocks Worth Buying This Week? When considering which stocks to invest in amidst current stock market conditions, most would look towards the health care sector. Among biotech stocks, one subsection, in particular, continues to make headlines. That is t...
Almost a month after Surrozen Inc (NASDAQ: SRZN) completed its business combination with a special purpose acquisition company (SPAC), Consonance-HFW Acquisition Corp, Stifel assumed coverage of the biotechnology company with a “buy” rating. Shares of the company j...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 109.0% to $0.3668 on volume of 102,385,159 shares Maxeon Solar Technologies Ltd. (MAXN) rose 4.3% to $0.181 on volume of 66,422,365 shares NVIDIA Corporation (NVDA) fell 1.3% to $126.58 on volume...
Targeted protein degradation (TPD * ) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s current SWEETS bispecific antibodies are unique TPD technologies Results demonstrated that the two new ASGR-targeted SWEETS bispecific a...
SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in preclinical models Treatment with SZN-043 in the Phase 1a trial was safe and well tolerated in healthy volunteers and patients with a history of liver cirrhosis Phase 1...